Journal profile · GASTROENTEROLOGY & HEPATOLOGY
Therapeutic Advances in Gastrointestinal Endoscopy
ISSN 2631-7745 · SAGE Publishing · United Kingdom
Therapeutic Advances in Gastrointestinal Endoscopy: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 1.2 (journal website); fully open access; APC about USD 2,650; median 132 days to acceptance (25 articles, last 24 months); 13 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Therapeutic Advances in Gastrointestinal Endoscopy is published by SAGE Publishing and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gallbladder and Bile Duct Disorders, Esophageal and GI Pathology and Colorectal Cancer Screening and Detection, together about 33.7% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Journal Highlights Re-launched in 2019 Listed in PubMed and indexed in Web of Science and Emerging Sources Citation Index (ESCI) Gold open access journal – all articles are made freely available online immediately upon publication Rigorous peer review Reaches a broad, multidisciplinary audience Official journal of the iCARE group Therapeutic Advances in Gastrointestinal Endoscopy is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of gastrointestinal endoscopy, with a strong focus on diagnostic and therapeutic advances. Please see the Aims and Scope tab for further information. Therapeutic Advances in Gastrointestinal Endoscopy is the official journal of the iCARE group. iCARE aims to bring together all those interested in capsule endoscopy and facilitate clinical and technological research by promoting scientific collaborations, exchanging ideas, and strengthening professional relationships between practitioners across Europe in clinical capsule endoscopy and related research fields. For more information, please click here. Diversity, Equity and Inclusion StatementTherapeutic Advances in Gastrointestinal Endoscopy promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the gastroenterology community.Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms. Submission information Submit your manuscript today at https://mc.manuscriptcentral.com/tgePlease see the Submission Guidelines tab for more information on how to submit your article to the journal. Open access article processing charge (APC) information The APC for this journal is currently $3200. The article processing charge for Plain Language Summary is $5500.The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here. Contact Please direct any queries to TAGEndoscopy@sagepub.co.uk
From the journal's Aims & Scope
Research area (LetPub): GASTROENTEROLOGY & HEPATOLOGY
Editorial board by country: none in mainland China; most named United States 13, Italy 9, United Kingdom 8, Germany 3, Japan 2 (52 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gallbladder and Bile Duct DisordersMedicine12.6%
- Esophageal and GI PathologyMedicine10.7%
- Colorectal Cancer Screening and DetectionMedicine10.4%
- Gastric Cancer Management and OutcomesMedicine8.9%
- Gastrointestinal Bleeding Diagnosis and TreatmentMedicine7.8%
- Pancreatic and Hepatic Oncology ResearchMedicine5.9%
- Pancreatitis Pathology and TreatmentMedicine5.6%
- Bariatric Surgery and OutcomesMedicine5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.2Publisher website ·
- 5-year impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 37OpenAlex ·
- 2-year mean citedness
- 1.24OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 12LetPub ·
Articles by year OpenAlex count · 116 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 14 | 14 | 3 |
| 2025 | 13 | 13 | 20 |
| 2024 | 14 | 14 | 28 |
| 2023 | 13 | 13 | 59 |
| 2022 | 12 | 12 | 138 |
| 2021 | 22 | 22 | 370 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
132 daysMedian, submission to acceptance · P25–P75 105 days – 156 days
- Acceptance to online
- median 38 days (27 articles)
- Submission to online
- median 165 days
- Sample
- 25 articles with submission and acceptance dates (30 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,650 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,650 | — | — | |
| LetPub | USD 2,650 | Yes | — | |
| Publisher website | USD 3,200 / USD 5,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Reference style
- Vancouver
Article types accepted8
- original articleView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
- original articlesOriginal Articles: The Editors will consider clinical interventional and observational studies with clearly stated aims, well-reported methodology (including ma…Length not stated
- perspectiveView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
- reviewView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
- review articleView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
- review articlesReview Articles: These manuscripts are usually commissioned by the Editors but unsolicited reviews will be considered.Length not stated
- scoping articlesScoping Articles: These reviews assess the scope of available literature on a topic through comprehensive synthesis. It may help determine whether a systematic …Length not stated
- systematic reviewView our Special Collections currently accepting submissions. Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstrac…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, this journal has adopted CRediT (Contributor Roles Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each author’s individual contributions to the work. You will be asked to list the contribution of each author as part of the submission process. Please…
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Therapeutic Advances in Gastrointestinal Endoscopy is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost o…
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized peer review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publishing
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2631-7745
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Therapeutic Advances in Gastrointestinal Endoscopy
What CAS zone is Therapeutic Advances in Gastrointestinal Endoscopy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Therapeutic Advances in Gastrointestinal Endoscopy is in Zone 3 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Therapeutic Advances in Gastrointestinal Endoscopy?
The journal's website gives an impact factor of 1.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.4, h-index 18.
How long does peer review take at Therapeutic Advances in Gastrointestinal Endoscopy?
Based on the dates recorded on 25 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 132 days (interquartile range 105–156 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Therapeutic Advances in Gastrointestinal Endoscopy based?
Of the 52 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (13), Italy (9) and United Kingdom (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Therapeutic Advances in Gastrointestinal Endoscopy?
According to LetPub and DOAJ records, Therapeutic Advances in Gastrointestinal Endoscopy is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PubMed; that list has not been checked against each database.
Is Therapeutic Advances in Gastrointestinal Endoscopy open access, and what is the APC?
Therapeutic Advances in Gastrointestinal Endoscopy is a fully open-access journal. APC about USD 2,650.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .